The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Neutrophils responsive to endogenous IFN-β regulate tumor angiogenesis and growth in a mouse tumor model
Open accessAbstract
Angiogenesis is a hallmark of malignant neoplasias, as the formation of new blood vessels is required for tumors to acquire oxygen and nutrients essential for their continued growth and metastasis. However, the signaling pathways leading to tumor vascularization are not fully understood. Here, using a transplantable mouse tumor model, we have demonstrated that endogenous IFN-beta inhibits tumor angiogenesis through repression of genes encoding proangiogenic and homing factors in tumor-infiltrating neutrophils. We determined that IFN-beta-deficient mice injected with B16F10 melanoma or MCA205 fibrosarcoma cells developed faster-growing tumors with better-developed blood vessels than did syngeneic control mice. These tumors displayed enhanced infiltration by CD11b+Gr1+ neutrophils expressing elevated levels of the genes encoding the proangiogenic factors VEGF and MMP9 and the homing receptor CXCR4. They also expressed higher levels of the transcription factors c-myc and STAT3, known regulators of VEGF, MMP9, and CXCR4. In vitro, treatment of these tumor-infiltrating neutrophils with low levels of IFN-beta restored expression of proangiogenic factors to control levels. Moreover, depletion of these neutrophils inhibited tumor growth in both control and IFN-beta-deficient mice. We therefore suggest that constitutively produced endogenous IFN-beta is an important mediator of innate tumor surveillance. Further, we believe our data help to explain the therapeutic effect of IFN treatment during the early stages of cancer development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,531
Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,859
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367
NF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1703 · Cited by 3,085
Fitzgerald, M., Hayward, I. P., Thomas, A. C., Campbell, J. H., & CAMPBELL, G. R. (1995) · Cited by 2,552
Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1194 · Cited by 1,860
Heissig, B., Hattori, K., Dias, S., Friedrich, M., Ferris, B., Hackett, N. R., Crystal, R. G., Besmer, P., Lyden, D., Moore, M. A. S., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00754-7 · Cited by 1,751
Interferons, immunity and cancer immunoediting
Dunn, G. P., Koebel, C. M., & Schreiber, R. D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1961 · Cited by 1,617
Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy
Lin, E. Y., Nguyen, A. V., Russell, R. G., & Pollard, J. W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.727 · Cited by 1,594
Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus Erythematosus
Roman, M. J., Shanker, B.-A., Davis, A., Lockshin, M. D., Sammaritano, L., Simantov, R., Crow, M. K., Schwartz, J. E., Paget, S. A., Devereux, R. B., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035471 · Cited by 1,427
Yang, L., DeBusk, L. M., Fukuda, K., Fingleton, B., Green-Jarvis, B., Shyr, Y., Matrisian, L. M., Carbone, D. P., & Lin, P. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.031 · Cited by 1,140
Du, R., Lu, K. V., Petritsch, C., Liu, P., Ganss, R., Passegué, E., Song, H., VandenBerg, S., Johnson, R. S., Werb, Z., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.034 · Cited by 1,130
VEGF-Induced Adult Neovascularization: Recruitment, Retention, and Role of Accessory Cells
Grunewald, M., Avraham, I., Dor, Y., Bachar-Lustig, E., Itin, A., Yung, S., Chimenti, S., Landsman, L., Abramovitch, R., & Keshet, E. (2006) · Cell · doi:10.1016/j.cell.2005.10.036 · Cited by 1,126
Disrupting tumour blood vessels
Tozer, G. M., Kanthou, C., & Baguley, B. C. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1628 · Cited by 930
Nozawa, H., Chiu, C., & Hanahan, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601807103 · Cited by 923
Premature Coronary-Artery Atherosclerosis in Systemic Lupus Erythematosus
Asanuma, Y., Oeser, A., Shintani, A. K., Turner, E., Olsen, N., Fazio, S., Linton, M. F., Raggi, P., & Stein, C. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035611 · Cited by 892
The significance of cancer cell expression of the chemokine receptor CXCR4
Balkwill, F. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.10.003 · Cited by 758
RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β
Takayanagi, H., Kim, S., Matsuo, K., Suzuki, H., Suzuki, T., Sato, K., Yokochi, T., Oda, H., Nakamura, K., Ida, N., et al. (2002) · Nature · doi:10.1038/416744a · Cited by 717
Busillo, J. M., & Benovic, J. L. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.11.002 · Cited by 617
Endogenous Inhibitors of Angiogenesis
Nyberg, P., Xie, L., & Kalluri, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2427 · Cited by 553
Guiducci, C., Vicari, A. P., Sangaletti, S., Trinchieri, G., & Colombo, M. P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4262 · Cited by 549
Jonasch, E., & Haluska, F. G. (2001) · The Oncologist · doi:10.1634/theoncologist.6-1-34 · Cited by 518
A weak signal for strong responses: interferon-alpha/beta revisited
Taniguchi, T., & Takaoka, A. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35073080 · Cited by 483
The Yin and Yang of type I interferon activity in bacterial infection
Decker, T., Müller, M., & Stockinger, S. (2005) · Nature Reviews Immunology · doi:10.1038/nri1684 · Cited by 468
Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin
Phung, T. L., Ziv, K., Dabydeen, D., Eyiah-Mensah, G., Riveros, M., Perruzzi, C., Sun, J., Monahan-Earley, R. A., Shiojima, I., Nagy, J. A., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.07.003 · Cited by 438
STAT3 is a potential modulator of HIF‐1‐mediated VEGF expression in human renal carcinoma cells
Jung, J. E., Lee, H., Cho, I., Chung, D. H., Yoon, S., Yang, Y. M., Lee, J. W., Choi, S., Park, J., Ye, S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3099fje · Cited by 425
Zlotnik, A. (2006) · International Journal of Cancer · doi:10.1002/ijc.22024 · Cited by 421
Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis
Darash-Yahana, M., Pikarsky, E., Abramovitch, R., Zeira, E., Pal, B., Karplus, R., Beider, K., Avniel, S., Kasem, S., Galun, E., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-0935fje · Cited by 421
Getts, D. R., Terry, R. L., Getts, M. T., Müller, M., Rana, S., Shrestha, B., Radford, J., Van Rooijen, N., Campbell, I. L., & King, N. J. C. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080421 · Cited by 360
Inhibition of tumor growth by elimination of granulocytes.
Pekarek, L. A., Starr, B. A., Toledano, A. Y., & Schreiber, H. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.1.435 · Cited by 340
Li, B., Sharpe, E. E., Maupin, A. B., Teleron, A. A., Pyle, A. L., Carmeliet, P., Young, P. P., Li, B., Sharpe, E. E., Maupin, A. B., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5137fje · Cited by 324
Cytokines as a link between innate and adaptive antitumor immunity
Belardelli, F. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02195-6 · Cited by 322
De Palma, M., Mazzieri, R., Politi, L. S., Pucci, F., Zonari, E., Sitia, G., Mazzoleni, S., Moi, D., Venneri, M. A., Indraccolo, S., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.09.004 · Cited by 301
Burger, M., Hartmann, T., Krome, M., Rawluk, J., Tamamura, H., Fujii, N., Kipps, T. J., & Burger, J. A. (2005) · Blood · doi:10.1182/blood-2004-12-4918 · Cited by 295
Denny, M. F., Thacker, S., Mehta, H., Somers, E. C., Dodick, T., Barrat, F. J., McCune, W. J., & Kaplan, M. J. (2007) · Blood · doi:10.1182/blood-2007-05-089086 · Cited by 282
Interferon-alpha as an immunotherapeutic protein.
Brassard, D., Grace, M. J., & Bordens, R. W. (2002) · PubMed · Cited by 247
Cytokine-mediated regulation of CXCR4 expression in human neutrophils
Nagase, H., Miyamasu, M., Yamaguchi, M., Imanishi, M., Tsuno, N. H., Matsushima, K., Yamamoto, K., Morita, Y., & Hirai, K. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.4.711 · Cited by 240
Molecular Mechanisms of Developmental and Tumor Angiogenesis
Plate, K. H., Breier, G., & Risau, W. (1994) · Brain Pathology · doi:10.1111/j.1750-3639.1994.tb00835.x · Cited by 227
Interferon-α as an immunotherapeutic protein
Brassard, D. L., Grace, M. J., & Bordens, R. W. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.4.565 · Cited by 223
Protective Role of Beta Interferon in Host Defense against Influenza A Virus
Koerner, I., Kochs, G., Kalinke, U., Weiss, S., & Staeheli, P. (2007) · Journal of Virology · doi:10.1128/jvi.01718-06 · Cited by 201
Self-citationThe Role of CC Chemokine Receptor 2 in Alveolar Monocyte and Neutrophil Immigration in Intact Mice
Maus, U., von Grote, K., Kuziel, W. A., Mack, M., Miller, E. J., Cihak, J., Stangassinger, M., Maus, R., Schlöndorff, D., Seeger, W., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2112012 · Cited by 195
Tumor Inflammatory Angiogenesis and Its Chemoprevention
Albini, A., Tosetti, F., Benelli, R., & Noonan, D. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-3473 · Cited by 194
Impaired Antiviral Response and Alpha/Beta Interferon Induction in Mice Lacking Beta Interferon
Deonarain, R., Alcamí, A., Alexiou, M., Dallman, M. J., Gewert, D. R., & Porter, A. C. G. (2000) · Journal of Virology · doi:10.1128/jvi.74.7.3404-3409.2000 · Cited by 171
Molecular mechanisms of tumor vascularization
Auguste, P., Lemière, S., Larrieu-Lahargue, F., & Bikfalvi, A. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.11.006 · Cited by 156
Qin, X.-Q., Tao, N., Dergay, A., Moy, P., Fawell, S. E., Davis, A. R., Wilson, J. M., & Barsoum, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14411 · Cited by 155
Reichel, C. A., Rehberg, M., Lerchenberger, M., Berberich, N., Bihari, P., Khandoga, A. G., Zahler, S., & Krombach, F. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.193268 · Cited by 152
Tabatabai, G., Frank, B., Möhle, R., Weller, M., & Wick, W. (2006) · Brain · doi:10.1093/brain/awl173 · Cited by 144
Yuan, Z., Guan, Y. A., Wang, L., Wei, W., Kane, A. B., & Chin, Y. E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9390-9400.2004 · Cited by 138
Selective reduction of c-myc mRNA in Daudi cells by human beta interferon.
Jonak, G. J., & Knight, E. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.6.1747 · Cited by 137
Chemokine receptors Ccr1, Ccr2, and Ccr5 mediate neutrophil migration to postischemic tissue
Reichel, C. A., Khandoga, A., Anders, H., Schlöndorff, D., Luckow, B., & Krombach, F. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0605337 · Cited by 127
Endogenous type I interferons as a defense against tumors
Gresser, I., & Belardelli, F. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00035-1 · Cited by 105
Walker, F., Zhang, H., Matthews, V. B., Weinstock, J., Nice, E. C., Ernst, M., Rose‐John, S., & Burgess, A. W. (2007) · Blood · doi:10.1182/blood-2007-10-119636 · Cited by 104
Wang, J. O., Lin, Q., Langston, H. P., & Cooper, M. D. (1995) · Immunity · doi:10.1016/1074-7613(95)90176-0 · Cited by 94
In Vivo Interleukin-6 Protects Neutrophils from Apoptosis in Osteomyelitis
Asensi, V., Valle, E., Meana, A., Fierer, J., Celada, A., Alvarez, V., Paz, J., Coto, E., Carton, J. A., Maradona, J. A., et al. (2004) · Infection and Immunity · doi:10.1128/iai.72.7.3823-3828.2004 · Cited by 93
Keulenaer, G. W. D., Ushio‐Fukai, M., Yin, Q., Chung, A. B., Lyons, P. R., Ishizaka, N., Kalpana, R., Taylor, W. R., Alexander, R. W., & Griendling, K. K. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.2.385 · Cited by 92
c-Myc activation by Theileria parasites promotes survival of infected B-lymphocytes
Dessauge, F., Hilaly, S., Baumgartner, M., Blumen, B., Werling, D., & Langsley, G. (2004) · Oncogene · doi:10.1038/sj.onc.1208314 · Cited by 91
Salmaggi, A., Gelati, M., Pollo, B., Frigerio, S., Eoli, M., Silvani, A., Broggi, G., Ciusani, E., Croci, D., Boiardi, A., et al. (2004) · Journal of Neuro-Oncology · doi:10.1023/b:neon.0000024241.05346.24 · Cited by 79
Deonarain, R., Verma, A., Porter, A. C. G., Gewert, D. R., Platanias, L. C., & Fish, E. N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2230460100 · Cited by 76
Hanahan, D. (1998) · Nature Medicine · doi:10.1038/nm0198-013 · Cited by 63
Significance of thymidine phosphorylase as a marker of protumor monocytes in breast cancer.
Toi, M., Ueno, T., Matsumoto, H., Saji, H., Funata, N., Koike, M., & Tominaga, T. (1999) · PubMed · Cited by 63
Sarkar, D., Park, E., & Fisher, P. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401829 · Cited by 53
Xue, M., Thakur, A. B., Cole, N., Lloyd, A. R., Stapleton, F. J., Wakefield, D., & Willcox, M. D. P. (2007) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100082 · Cited by 50
Chanprasert, S., Geddis, A. E., Barroga, C. F., Fox, N. E., & Kaushansky, K. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.09.010 · Cited by 44
Role of hematopoietic lineage cells as accessory components in blood vessel formation
Takakura, N. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00223.x · Cited by 39
Interferon beta increases c-Myc proteolysis in mouse monocyte/macrophage leukemia cells
Hu, X., Bies, J., & Wolff, L. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.04.002 · Cited by 9
Cited by
Neutrophil recruitment and function in health and inflammation
Kolaczkowska, E., & Kubes, P. (2013) · Nature Reviews Immunology · doi:10.1038/nri3399 · Cited by 5,472
Neutrophils in the activation and regulation of innate and adaptive immunity
Mantovani, A., Cassatella, M. A., Costantini, C., & Jaillon, S. (2011) · Nature Reviews Immunology · doi:10.1038/nri3024 · Cited by 3,027
Mao, X., Xu, J., Wang, W., Liang, C., Hua, J., Liu, J., Zhang, B., Meng, Q., Yu, X., & Shi, S. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01428-1 · Cited by 2,290
Microenvironmental regulation of tumour angiogenesis
De Palma, M., Biziato, D., & Petrova, T. V. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.51 · Cited by 1,847
Neutrophils in cancer: Neutral no more
Coffelt, S. B., Wellenstein, M. D., & de Visser, K. E. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.52 · Cited by 1,830
Metadata
- Authors
- Jablonska, J., Leschner, S., Westphal, K., Lienenklaus, S., & Weiss, S.
- Venue
- Journal of Clinical Investigation
- Published
- 2010-04-01
- Volume
- 120
- Issue
- 4
- Pages
- 1151-1164
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2023962283
- Cited by
- 564
- References
- 67
- FWCI
- 7.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.